Urinary liver-type fatty acid-binding protein level as a prognostic indicator of acute kidney injury secondary to severe falciparum malaria.
Yuri KatayamaKeiki ShimadaDaisuke KatagiriKanako TerakawaEmi SakamotoTakahito NiikuraMinami SuzukiYuki YoshizakiLubna SatoGen YamadaYutaro AkiyamaSekiko TanedaHideki TakanoPublished in: CEN case reports (2024)
Acute kidney injury (AKI) secondary to severe falciparum malaria possesses a high mortality rate; however, a prognostic marker of renal dysfunction has not yet been identified. Thus, we reported a case of a patient with AKI secondary to falciparum malaria who underwent hemodialysis and a renal biopsy due to prolonged renal dysfunction. The male patient, in his 50 s, presented to our hospital with vomiting, diarrhea, fever, and decreased level of consciousness. The Giemsa-stained peripheral blood film revealed approximately 5% parasitemia, and a rapid diagnostic test was positive for Plasmodium falciparum. He was diagnosed with severe falciparum malaria and was started on quinine hydrochloride. Hemodialysis was initiated due to the decreased urine output and fluid retention. Subsequently, he was weaned off hemodialysis. The histopathological analysis of a renal biopsy revealed interstitial fibrosis, tubular atrophy, and chronic inflammatory cell infiltration; thus, malarial nephropathy was diagnosed. Thereafter, his renal function stabilized, and he was discharged from the hospital. The urinary liver-type fatty acid-binding protein (L-FABP) level decreased before renal function improved. Our report highlighted that long-term follow-up is essential for severe AKI secondary to malaria. The urinary L-FABP level may be a useful prognostic indicator of AKI secondary to severe falciparum malaria.
Keyphrases
- plasmodium falciparum
- acute kidney injury
- binding protein
- cardiac surgery
- fatty acid
- early onset
- peripheral blood
- single cell
- oxidative stress
- peritoneal dialysis
- drug induced
- chronic kidney disease
- healthcare
- stem cells
- type diabetes
- adverse drug
- mesenchymal stem cells
- fine needle aspiration
- ionic liquid
- liver fibrosis